Systematic review with meta‐analysis: the efficacy of vonoprazan‐based triple therapy on Helicobacter pylori eradication
Alimentary Pharmacology & Therapeutics2017Vol. 46(2), pp. 106–114
Citations Over TimeTop 1% of 2017 papers
Abstract
The vonoprazan-based triple therapy showed superior efficacy in terms of H. pylori eradication as compared to the PPI-based triple therapy. In addition, the vonoprazan-based triple therapy showed comparable tolerability and incidence of adverse events.
Related Papers
- → Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy(2021)39 cited
- → Hypothyroidism and levothyroxine therapy following bariatric surgery: a systematic review, meta-analysis, network meta-analysis, and meta-regression(2021)32 cited
- → INFLUENCE EXERTED BY HELICOBACTER PYLORI ON CONCENTRATIONS OF ANTI-INFLAMMATORY Т-CELL CYTOKINES AND SUNPOPULATIONS THAT PRODUCE THEM(2018)2 cited
- → The Effects of Two Novel Copper-Based Formulations on Helicobacter pylori(2013)2 cited
- → Вплив токсигенних штамів Helicobacter pylori на тяжкість перебігу хронічної гастродуоденальної патології у дітей(2014)